$35.88

+0.97 (+2.78%)

Weekly Expected Move ±7.3%

$31 $33 $36 $38 $41

NASDAQ · Healthcare · Medical - Care Facilities · Tech Score Neutral · Power 41 · $1.8B mcap · 39M float · 1.38% daily turnover · Short 77% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE

32.7 / 100

NoneWeakNarrowWide

Primary source: Cost Advantage · ROIC: 4.7% · 5Y Avg: 12.2%

Cost Advantage ★

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ASTH has No discernible competitive edge (32.7/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. ROIC of 4.7% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$53

Low

$54

Avg Target

$55

High

Based on 3 analysts since Aug 6, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 11Hold: 0Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$56.50

Analysts4

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-09-15	Oppenheimer	Michael Wiederhorn	Initiated	$53	—	+33.8%	$39.60
2026-08-10	Truist Financial	—	$47	$55	+8	+46.8%	$37.47
2026-08-07	Barclays	—	$50	$53	+3	+55.3%	$34.13
2026-07-14	BTIG	David Larsen	$40	$65	+25	+36.4%	$47.64
2026-05-26	Barclays	—	$37	$50	+13	+28.2%	$39.00
2026-05-14	Truist Financial	—	Initiated	$47	—	+19.3%	$39.39
2026-05-11	Barclays	—	$26	$37	+11	-5.9%	$39.30
2026-05-08	Needham	Matthew Shea	$28	$41	+13	+8.2%	$37.90
2026-05-08	Robert W. Baird	—	$40	$45	+5	+24.9%	$36.03
2026-04-15	Robert W. Baird	—	$50	$40	-10	+37.6%	$29.07
2026-02-02	BTIG	—	$70	$40	-30	+75.9%	$22.74
2025-12-12	Needham	Matthew Shea	Initiated	$28	—	+24.7%	$22.46
2025-11-25	Jefferies	—	Initiated	$37	—	+61.5%	$22.91
2025-11-24	Barclays	Andrew Mok	$36	$26	-10	+15.6%	$22.50
2025-04-01	Barclays	—	Initiated	$36	—	+20.6%	$29.86
2025-03-03	Robert W. Baird	—	$67	$50	-17	+88.8%	$26.48
2024-10-03	BTIG	David Larsen	Initiated	$70	—	+21.0%	$57.87
2024-08-15	Robert W. Baird	Michael Ha	Initiated	$67	—	+43.8%	$46.58
2024-06-27	Stifel Nicolaus	Chris O'Cull	Initiated	$48	—	+18.5%	$40.50

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

Oct 02, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ASTH receives an overall rating of B. Strongest factors: DCF (5/5), ROA (4/5). Areas of concern: D/E (1/5), P/E (1/5).

Rating Change History

Date	From	To
2026-10-01	B-	B
2026-08-31	B	B-
2026-07-01	B+	B
2026-05-11	A-	B+
2026-05-08	B	A-
2026-03-06	B+	B
2026-03-02	B	B+
2026-02-06	B-	B
2026-01-03	B	B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 62 Grade C

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

100

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ASTH scores highest in Momentum (100/100) and lowest in Profitability (13/100). A grade of C represents mixed fundamentals — strengths in some areas offset by weaknesses.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

2.99

Safe Zone

Piotroski F-Score

5/9

✓ ✓ ✓ ✓ ✗ ✗ ✗ ✗ ✓

Beneish M-Score

-2.10

Unlikely Manipulator

Ohlson O-Score

-6.04

Bankruptcy prob: 0.2%

Low Risk

Credit Rating

BBB-

Score: 53.2/100

Trend: Deteriorating

Earnings Quality

75/100

OCF/NI: 4.34x

Accruals: -7.3%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ASTH scores 2.99, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ASTH scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ASTH's score of -2.10 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ASTH's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ASTH receives an estimated rating of BBB- (score: 53.2/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ASTH's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

43.35x

PEG

0.77x

P/S

0.46x

P/B

2.12x

P/FCF

14.58x

P/OCF

13.13x

EV/EBITDA

16.52x

EV/Revenue

0.75x

EV/EBIT

22.67x

EV/FCF

18.23x

Earnings Yield

1.76%

FCF Yield

6.86%

Shareholder Yield

1.09%

Graham Number

$17.48

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 43.4x earnings, ASTH is priced for high growth expectations. Graham's intrinsic value formula yields $17.48 per share, 105% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.675

NI / EBT

Interest Burden

0.472

EBT / EBIT

EBIT Margin

0.033

EBIT / Rev

Asset Turnover

2.064

Rev / Assets

Equity Multiplier

2.334

Assets / Equity

ROE

5.1%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ASTH's ROE of 5.1% is driven by Asset Turnover (2.064), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

15.00%

Fair P/E

38.50x

Intrinsic Value

$31.36

Price/Value

1.48x

Margin of Safety

-47.99%

Premium

47.99%

Assessment

Neutral

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ASTH's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. ASTH trades at a 48% premium to its adjusted intrinsic value of $31.36, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 43.4x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$35.88

Median 1Y

$33.62

5th Pctile

$11.84

95th Pctile

$95.64

Ann. Volatility

62.0%

Analyst Target

$56.50

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Brandon K. Sim, M.S. Chief Executive Officer	$850,000	$11,999,980	$14,930,231
Dinesh Kumar, M.D. Chief Medical Officer	$700,000	$2,199,997	$4,283,715
Chandan Basho, M.B.A. Chief Financial Officer and Chief Operating Officer	$678,077	$2,199,997	$3,867,057
Kenneth Sim, M.D. Executive Chairman	$950,000	$—	$1,074,170

CEO Pay Ratio

206:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $14,930,231

Avg Employee Cost (SGA/emp): $72,419

Employees: 3,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

3,000

+57.9% YoY

Revenue / Employee

$1,060,590

Rev: $3,181,769,000

Profit / Employee

$7,496

NI: $22,487,000

SGA / Employee

$72,419

Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	10.8%	13.5%	15.7%	16.7%	13.2%	9.3%	8.8%	9.0%	8.3%	10.5%	10.3%	11.0%	9.6%	6.5%	5.0%	3.5%	1.3%	3.0%	3.9%	5.1%	5.08%
ROA	5.4%	7.0%	8.2%	8.0%	6.9%	5.1%	4.8%	4.7%	4.5%	6.4%	5.6%	6.0%	5.3%	3.8%	2.7%	1.9%	0.5%	1.3%	1.6%	2.2%	2.18%
ROIC	16.8%	13.0%	16.1%	-6.4%	9.3%	11.9%	10.8%	11.9%	10.8%	8.5%	8.1%	8.1%	7.0%	6.2%	5.0%	4.3%	1.4%	3.3%	3.9%	4.7%	4.65%
ROCE	10.8%	8.0%	10.6%	1.6%	7.6%	11.6%	11.8%	13.6%	12.9%	14.8%	13.2%	12.8%	11.7%	11.5%	10.2%	8.4%	4.4%	5.6%	6.7%	8.3%	8.30%
Gross Margin	35.1%	11.9%	16.2%	14.7%	24.0%	14.0%	14.2%	15.9%	20.9%	11.0%	17.0%	13.6%	15.4%	9.5%	11.5%	11.9%	8.5%	8.3%	9.4%	10.7%	10.70%
Operating Margin	23.4%	1.2%	10.0%	5.7%	15.8%	4.3%	6.6%	7.8%	11.2%	-1.1%	7.5%	6.2%	5.9%	0.1%	3.3%	3.1%	2.0%	1.9%	3.0%	3.5%	3.53%
Net Margin	15.1%	7.1%	5.2%	4.4%	7.3%	-0.9%	3.9%	3.8%	6.3%	3.5%	3.7%	3.9%	3.4%	-1.0%	1.1%	1.4%	0.0%	0.6%	1.5%	2.0%	2.03%
EBITDA Margin	0.1%	-8.7%	9.0%	8.5%	15.3%	5.8%	8.0%	11.3%	13.2%	3.2%	9.1%	9.9%	9.0%	2.1%	3.8%	4.8%	4.1%	4.4%	5.3%	4.4%	4.44%
FCF Margin	14.0%	6.9%	5.6%	4.3%	-3.8%	5.2%	3.7%	4.7%	8.4%	2.9%	3.6%	3.1%	4.1%	2.2%	2.3%	5.0%	3.3%	3.3%	4.4%	4.1%	4.12%
OCF Margin	18.0%	10.1%	9.8%	7.5%	-1.4%	7.2%	5.4%	6.4%	10.1%	4.9%	4.6%	4.0%	4.8%	2.6%	2.8%	5.4%	3.7%	3.6%	4.7%	4.6%	4.58%
ROE 3Y Avg	snapshot only																				6.09%
ROE 5Y Avg	snapshot only																				8.38%
ROA 3Y Avg	snapshot only																				3.00%
ROIC 3Y Avg	snapshot only																				5.34%
ROIC Economic	snapshot only																				3.78%
Cash ROA	snapshot only																				7.71%
Cash ROIC	snapshot only																				12.49%
CROIC	snapshot only																				11.25%
NOPAT Margin	snapshot only																				1.71%
Pretax Margin	snapshot only																				1.56%
R&D / Revenue	snapshot only																				0.00%
SGA / Revenue	snapshot only																				6.20%
SBC / Revenue	snapshot only																				1.12%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	89.76	55.56	29.94	24.08	28.72	29.77	37.50	31.53	31.63	29.98	32.19	28.44	44.74	35.02	43.27	48.73	147.06	54.64	39.79	56.98	43.354
P/S Ratio	10.46	5.64	2.59	1.86	1.72	1.20	1.41	1.14	1.09	1.31	1.38	1.22	1.62	0.74	0.67	0.51	0.48	0.39	0.34	0.60	0.463
P/B Ratio	9.67	7.53	4.70	3.70	3.53	2.54	3.06	2.61	2.44	2.96	3.07	2.87	3.97	2.12	2.03	1.61	1.81	1.58	1.50	2.78	2.123
P/FCF	74.90	81.75	46.63	42.90	-45.16	23.28	37.63	24.18	12.98	45.85	38.32	39.31	39.98	34.22	29.07	10.15	14.46	11.76	7.76	14.58	14.581
P/OCF	58.05	55.86	26.41	24.63	—	16.78	26.02	17.90	10.81	26.68	30.22	30.47	33.89	28.95	24.10	9.43	13.16	10.72	7.24	13.13	13.131
EV/EBITDA	44.99	44.60	22.07	58.07	23.14	11.72	14.41	10.70	10.86	14.92	15.78	14.75	21.04	11.93	13.23	11.92	18.73	13.88	10.99	16.52	16.516
EV/Revenue	10.13	5.50	2.50	1.81	1.73	1.15	1.36	1.09	1.06	1.33	1.45	1.32	1.70	0.83	0.76	0.55	0.70	0.59	0.51	0.75	0.751
EV/EBIT	49.90	54.44	26.97	144.92	30.03	13.90	16.98	12.32	12.49	17.41	18.33	17.42	25.59	14.86	17.18	16.11	28.67	20.97	16.50	22.67	22.669
EV/FCF	72.53	79.67	44.97	41.68	-45.30	22.20	36.51	23.08	12.61	46.47	40.16	42.30	41.77	38.31	32.72	11.02	20.90	17.97	11.55	18.23	18.233
Earnings Yield	1.1%	1.8%	3.3%	4.2%	3.5%	3.4%	2.7%	3.2%	3.2%	3.3%	3.1%	3.5%	2.2%	2.9%	2.3%	2.1%	0.7%	1.8%	2.5%	1.8%	1.76%
FCF Yield	1.3%	1.2%	2.1%	2.3%	-2.2%	4.3%	2.7%	4.1%	7.7%	2.2%	2.6%	2.5%	2.5%	2.9%	3.4%	9.9%	6.9%	8.5%	12.9%	6.9%	6.86%
PEG Ratio	snapshot only																				0.766
EV/OCF	snapshot only																				16.420
EV/Gross Profit	snapshot only																				8.148
Acquirers Multiple	snapshot only																				28.757
Shareholder Yield	snapshot only																				1.09%
Graham Number	snapshot only																				$17.48

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	3.66	3.53	2.77	2.49	2.84	2.88	2.76	2.50	2.35	2.11	1.51	1.84	1.91	1.75	1.70	1.59	1.40	1.40	1.35	1.23	1.229
Quick Ratio	3.66	3.53	2.77	2.49	2.84	2.88	2.76	2.50	2.35	2.11	1.51	1.84	1.91	1.75	1.70	1.59	1.40	1.40	1.35	1.23	1.229
Debt/Equity	0.46	0.45	0.43	0.47	0.44	0.42	0.41	0.41	0.40	0.52	0.66	0.70	0.68	0.66	0.61	0.58	1.40	1.38	1.33	1.18	1.180
Net Debt/Equity	-0.31	-0.19	-0.17	-0.11	0.01	-0.12	-0.09	-0.12	-0.07	0.04	0.15	0.22	0.18	0.25	0.26	0.14	0.80	0.83	0.73	0.70	0.697
Debt/Assets	0.23	0.23	0.22	0.23	0.24	0.24	0.23	0.22	0.22	0.34	0.35	0.38	0.37	0.35	0.34	0.31	0.49	0.49	0.45	0.43	0.429
Debt/EBITDA	2.20	2.73	2.07	7.51	2.86	2.05	1.98	1.75	1.82	2.60	3.25	3.35	3.43	3.33	3.50	3.99	10.05	7.97	6.54	5.60	5.600
Net Debt/EBITDA	-1.47	-1.16	-0.81	-1.70	0.07	-0.57	-0.44	-0.51	-0.32	0.20	0.72	1.04	0.90	1.28	1.48	0.94	5.77	4.79	3.60	3.31	3.308
Interest Coverage	28.99	15.60	16.13	2.41	9.40	11.93	9.67	9.63	8.50	6.58	5.63	4.74	3.75	3.44	3.02	2.62	1.75	1.79	1.85	1.89	1.892
Equity Multiplier	2.00	1.94	1.92	1.98	1.85	1.78	1.77	1.81	1.81	1.52	1.88	1.84	1.82	1.90	1.79	1.88	2.88	2.85	2.95	2.75	2.749
Cash Ratio	snapshot only																				0.536
Debt Service Coverage	snapshot only																				2.598
Cash to Debt	snapshot only																				0.409
FCF to Debt	snapshot only																				0.162
Defensive Interval	snapshot only																				1283.3 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.46	0.69	0.94	1.04	1.15	1.25	1.28	1.31	1.32	1.46	1.31	1.40	1.46	1.78	1.76	1.80	1.64	1.78	1.91	2.06	2.064
Inventory Turnover	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Receivables Turnover	5.56	56.36	6.54	8.16	8.97	18.25	8.62	8.69	7.73	11.07	8.72	9.06	10.93	9.88	10.63	8.79	11.28	9.78	9.96	9.45	9.447
Payables Turnover	12.31	82.63	68.53	68.54	35.61	118.19	85.32	101.43	64.12	119.88	24.66	55.86	63.97	145.46	39.62	81.19	21.10	307.32	92.38	26.82	26.824
DSO	66	6	56	45	41	20	42	42	47	33	42	40	33	37	34	42	32	37	37	39	38.6 days
DIO	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.0 days
DPO	30	4	5	5	10	3	4	4	6	3	15	7	6	3	9	4	17	1	4	14	13.6 days
Cash Conversion Cycle	36	2	50	39	30	17	38	38	42	30	27	34	28	34	25	37	15	36	33	25	25.0 days
Fixed Asset Turnover	snapshot only																				37.777
Cash Velocity	snapshot only																				9.591
Capital Intensity	snapshot only																				0.594

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	—	—	—	4.4%	1.6%	91.4%	41.5%	35.8%	27.1%	21.2%	19.3%	22.8%	29.7%	46.7%	54.8%	52.0%	68.2%	56.4%	56.7%	58.9%	58.91%
Net Income	—	—	—	4.8%	33.5%	-23.7%	-38.7%	-36.4%	-27.0%	31.1%	36.7%	45.9%	36.5%	-28.9%	-43.9%	-63.1%	-84.7%	-47.9%	-13.6%	60.5%	60.53%
EPS	—	—	—	4.8%	33.9%	-24.8%	-39.9%	-37.5%	-28.2%	28.5%	34.1%	42.3%	32.8%	-29.5%	-45.1%	-64.2%	-85.1%	-49.6%	-14.0%	59.5%	59.54%
FCF	—	—	—	1.9%	-1.7%	43.5%	-4.8%	47.6%	3.8%	-32.9%	15.2%	-19.0%	-37.3%	11.3%	-0.6%	1.4%	38.7%	1.4%	2.0%	30.7%	30.68%
EBITDA	—	—	—	-67.2%	-14.0%	52.1%	18.4%	3.4%	66.0%	10.4%	15.7%	7.6%	7.1%	14.7%	-3.4%	-21.0%	-22.1%	-4.6%	26.3%	56.0%	56.02%
Op. Income	—	—	—	3.6%	26.7%	36.5%	-2.1%	15.5%	7.6%	-18.8%	-8.0%	-14.9%	-16.1%	5.6%	-13.6%	-26.6%	-28.2%	-12.1%	8.4%	43.4%	43.37%
OCF Growth	snapshot only																				34.75%
Asset Growth	snapshot only																				58.22%
Equity Growth	snapshot only																				8.46%
Debt Growth	snapshot only																				1.19%
Shares Change	snapshot only																				0.62%
Dividend Growth	snapshot only																				-76.80%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	—	—	—	—	—	—	—	—	—	—	—	1.1%	62.3%	50.4%	37.7%	36.3%	40.5%	40.6%	42.5%	43.7%	43.66%
Revenue 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	85.4%	85.37%
EPS 3Y	—	—	—	—	—	—	—	—	—	—	—	72.8%	8.5%	-12.0%	-23.8%	-31.7%	-47.8%	-23.0%	-14.1%	-6.7%	-6.68%
EPS 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	24.1%	24.15%
Net Income 3Y	—	—	—	—	—	—	—	—	—	—	—	75.5%	10.0%	-10.8%	-22.2%	-30.0%	-46.6%	-21.4%	-12.8%	-4.7%	-4.73%
Net Income 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	26.2%	26.22%
EBITDA 3Y	—	—	—	—	—	—	—	—	—	—	—	16.2%	15.2%	24.4%	9.8%	55.7%	11.5%	6.5%	12.2%	9.9%	9.87%
EBITDA 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	14.1%	14.08%
Gross Profit 3Y	—	—	—	—	—	—	—	—	—	—	—	84.3%	27.6%	24.0%	14.0%	15.6%	17.4%	15.8%	17.1%	17.2%	17.15%
Gross Profit 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	55.2%	55.16%
Op. Income 3Y	—	—	—	—	—	—	—	—	—	—	—	65.7%	4.6%	5.4%	-8.0%	-10.3%	-13.5%	-9.0%	-4.9%	-3.6%	-3.58%
Op. Income 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	36.8%	36.77%
FCF 3Y	—	—	—	—	—	—	—	—	—	—	—	52.1%	7.5%	2.3%	2.9%	43.1%	—	20.9%	50.5%	37.4%	37.36%
FCF 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	62.3%	62.30%
OCF 3Y	—	—	—	—	—	—	—	—	—	—	—	44.1%	4.3%	-4.7%	-9.4%	21.9%	—	11.7%	36.1%	28.7%	28.67%
OCF 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	52.5%	52.49%
Assets 3Y	—	—	—	—	—	—	—	—	—	—	—	11.9%	13.8%	16.0%	13.4%	14.9%	33.4%	31.9%	33.4%	30.5%	30.49%
Assets 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	20.6%	20.60%
Equity 3Y	—	—	—	—	—	—	—	—	—	—	—	19.1%	17.4%	16.7%	16.3%	16.8%	15.0%	12.8%	12.6%	13.6%	13.62%
Book Value 3Y	—	—	—	—	—	—	—	—	—	—	—	17.3%	15.8%	15.1%	14.0%	14.1%	12.3%	10.5%	11.0%	11.3%	11.29%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	2.0%	1.5%	-60.4%	-47.8%	-50.2%	-50.1%	22.5%	-36.3%	-39.7%	-39.69%

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	—	—	—	—	—	—	—	0.95	0.95	0.95	0.99	0.94	0.97	0.97	0.93	0.94	0.89	0.92	0.92	0.93	0.931
Earnings Stability	—	—	—	—	—	—	—	0.31	0.00	0.00	0.17	0.43	0.17	0.28	0.56	0.01	0.30	0.64	0.71	0.00	0.001
Margin Stability	—	—	—	—	—	—	—	0.86	0.65	0.77	0.84	0.84	0.65	0.74	0.77	0.80	0.78	0.76	0.74	0.67	0.666
Rev. Growth Consistency	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	0.00	0.00	0.00	0.50	0.50	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.500
FCF Positive Streak	0	0	0	1	0	1	1	1	0	1	1	1	1	1	1	1	1	1	1	1	1
Earnings Persistence	—	—	—	—	—	—	—	0.85	0.89	0.88	0.85	0.82	0.85	0.88	0.82	0.50	0.50	0.81	0.95	0.50	0.500
Earnings Smoothness	—	—	—	0.00	0.71	0.73	0.52	0.55	0.69	0.73	0.69	0.63	0.69	0.66	0.44	0.08	0.00	0.37	0.85	0.54	0.535
ROE Trend	—	—	—	—	—	—	—	-0.01	-0.04	-0.01	-0.02	-0.02	-0.01	-0.03	-0.04	-0.06	-0.07	-0.05	-0.03	-0.02	-0.018
Gross Margin Trend	—	—	—	—	—	—	—	-0.04	-0.07	-0.05	-0.03	-0.03	-0.03	-0.03	-0.04	-0.04	-0.05	-0.05	-0.05	-0.04	-0.044
FCF Margin Trend	—	—	—	—	—	—	—	-0.01	0.03	-0.03	-0.01	-0.01	0.02	-0.02	-0.01	0.01	-0.03	0.01	0.01	0.00	0.001
Sustainable Growth Rate	3.6%	6.6%	8.9%	11.6%	10.6%	6.5%	6.3%	8.5%	7.6%	-0.2%	0.1%	0.9%	0.1%	5.9%	3.7%	2.3%	0.2%	2.0%	3.6%	4.8%	4.84%
Internal Growth Rate	1.9%	3.5%	4.9%	5.9%	5.8%	3.6%	3.6%	4.7%	4.4%	—	0.0%	0.5%	0.0%	3.5%	2.0%	1.3%	0.1%	0.8%	1.5%	2.1%	2.12%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	1.55	0.99	1.13	0.98	-0.24	1.77	1.44	1.76	2.93	1.12	1.07	0.93	1.32	1.21	1.80	5.17	11.17	5.10	5.49	4.34	4.339
FCF/OCF	0.78	0.68	0.57	0.57	2.66	0.72	0.69	0.74	0.83	0.58	0.79	0.78	0.85	0.85	0.83	0.93	0.91	0.91	0.93	0.90	0.901
FCF/Net Income	snapshot only																				3.907
OCF/EBITDA	snapshot only																				1.006
CapEx/Revenue	4.1%	3.2%	4.3%	3.2%	2.4%	2.0%	1.7%	1.7%	1.7%	2.1%	1.0%	0.9%	0.7%	0.4%	0.5%	0.4%	0.3%	0.3%	0.3%	0.5%	0.46%
CapEx/Depreciation	snapshot only																				0.368
Accruals Ratio	-0.03	0.00	-0.01	0.00	0.09	-0.04	-0.02	-0.04	-0.09	-0.01	-0.00	0.00	-0.02	-0.01	-0.02	-0.08	-0.06	-0.05	-0.07	-0.07	-0.073
Sloan Accruals	snapshot only																				-0.078
Cash Flow Adequacy	snapshot only																				9.046
Earnings Quality Score	snapshot only																				0.750

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.7%	0.9%	1.4%	1.3%	0.7%	1.0%	0.8%	0.2%	0.3%	3.4%	3.1%	3.2%	2.2%	0.3%	0.6%	0.7%	0.6%	0.6%	0.2%	0.1%	0.00%
Dividend/Share	$0.67	$0.68	$0.70	$0.49	$0.27	$0.30	$0.28	$0.05	$0.08	$1.31	$1.30	$1.32	$1.28	$0.08	$0.19	$0.17	$0.17	$0.16	$0.05	$0.04	$0.00
Payout Ratio	66.2%	51.2%	43.3%	30.6%	20.2%	30.3%	28.4%	4.9%	7.9%	1.0%	99.4%	92.3%	99.1%	9.4%	26.8%	33.1%	86.5%	35.1%	8.4%	4.8%	4.82%
FCF Payout Ratio	55.3%	75.3%	67.5%	54.4%	—	23.7%	28.5%	3.8%	3.2%	1.6%	1.2%	1.3%	88.6%	9.1%	18.0%	6.9%	8.5%	7.5%	1.6%	1.2%	1.23%
Total Payout Ratio	77.7%	60.1%	50.9%	47.1%	35.6%	50.3%	69.0%	24.8%	28.2%	1.2%	1.0%	93.2%	1.0%	11.5%	33.3%	36.9%	94.2%	1.1%	66.4%	62.1%	62.06%
Div. Increase Streak	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Chowder Number	—	—	—	0.08	-0.59	-0.54	-0.59	-0.90	-0.71	3.46	3.81	26.29	16.13	-0.93	-0.84	-0.86	-0.86	0.96	-0.73	-0.77	-0.766
Buyback Yield	0.1%	0.2%	0.3%	0.7%	0.5%	0.7%	1.1%	0.6%	0.6%	0.6%	0.0%	0.0%	0.0%	0.1%	0.1%	0.1%	0.1%	1.3%	1.5%	1.0%	1.00%
Net Buyback Yield	0.1%	0.1%	0.1%	0.6%	0.4%	0.7%	1.1%	0.6%	0.6%	0.6%	0.0%	0.0%	0.0%	0.1%	0.1%	0.1%	0.0%	1.3%	1.4%	1.0%	1.00%
Total Shareholder Return	0.9%	1.0%	1.6%	1.8%	1.1%	1.7%	1.8%	0.8%	0.9%	4.0%	3.1%	3.3%	2.3%	0.3%	0.8%	0.7%	0.6%	1.9%	1.6%	1.1%	1.09%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	0.59	1.07	1.00	10.60	1.17	0.53	0.52	0.46	0.46	0.68	0.66	0.72	0.75	0.53	0.53	0.49	0.32	0.57	0.61	0.67	0.675
Interest Burden (EBT/EBIT)	0.97	0.94	0.94	0.58	0.89	0.92	0.90	0.90	0.88	0.85	0.82	0.79	0.73	0.71	0.67	0.62	0.43	0.44	0.46	0.47	0.472
EBIT Margin	0.20	0.10	0.09	0.01	0.06	0.08	0.08	0.09	0.08	0.08	0.08	0.08	0.07	0.06	0.04	0.03	0.02	0.03	0.03	0.03	0.033
Asset Turnover	0.46	0.69	0.94	1.04	1.15	1.25	1.28	1.31	1.32	1.46	1.31	1.40	1.46	1.78	1.76	1.80	1.64	1.78	1.91	2.06	2.064
Equity Multiplier	2.00	1.94	1.92	2.09	1.92	1.85	1.84	1.89	1.83	1.64	1.83	1.83	1.82	1.72	1.83	1.87	2.38	2.40	2.39	2.33	2.334

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$1.01	$1.32	$1.62	$1.60	$1.36	$0.99	$0.97	$1.00	$0.98	$1.28	$1.30	$1.43	$1.30	$0.90	$0.72	$0.51	$0.19	$0.45	$0.62	$0.81	$0.81
Book Value/Share	$9.42	$9.76	$10.31	$10.43	$11.06	$11.65	$11.93	$12.10	$12.65	$12.92	$13.66	$14.15	$14.61	$14.87	$15.26	$15.47	$15.68	$15.73	$16.31	$16.68	$12.19
Tangible Book/Share	$2.35	$2.59	$3.08	$3.26	$3.89	$4.22	$4.39	$4.65	$5.20	$5.55	$2.58	$3.19	$3.85	$3.66	$4.44	$4.91	$-7.54	$-7.18	$-6.76	$-6.03	$-6.03
Revenue/Share	$8.70	$13.03	$18.72	$20.75	$22.64	$24.57	$25.94	$27.72	$28.30	$29.18	$30.38	$33.18	$35.72	$42.45	$46.07	$48.90	$58.55	$64.24	$71.89	$77.23	$78.27
FCF/Share	$1.22	$0.90	$1.04	$0.90	$-0.86	$1.27	$0.97	$1.31	$2.38	$0.84	$1.10	$1.03	$1.45	$0.92	$1.07	$2.45	$1.96	$2.11	$3.16	$3.18	$3.23
OCF/Share	$1.57	$1.32	$1.84	$1.57	$-0.33	$1.76	$1.40	$1.77	$2.85	$1.44	$1.39	$1.33	$1.71	$1.09	$1.29	$2.64	$2.15	$2.31	$3.38	$3.53	$3.58
Cash/Share	$7.20	$6.24	$6.11	$5.95	$4.71	$6.30	$5.95	$6.36	$5.90	$6.23	$7.05	$6.83	$7.27	$6.07	$5.34	$6.92	$9.37	$8.67	$9.75	$8.05	$8.16
EBITDA/Share	$1.96	$1.61	$2.12	$0.65	$1.69	$2.41	$2.46	$2.82	$2.76	$2.60	$2.79	$2.96	$2.88	$2.96	$2.64	$2.27	$2.19	$2.73	$3.32	$3.51	$3.51
Debt/Share	$4.32	$4.38	$4.38	$4.85	$4.83	$4.92	$4.87	$4.92	$5.02	$6.75	$9.06	$9.91	$9.87	$9.84	$9.24	$9.05	$21.98	$21.77	$21.71	$19.68	$19.68
Net Debt/Share	$-2.88	$-1.86	$-1.72	$-1.10	$0.13	$-1.38	$-1.08	$-1.44	$-0.88	$0.52	$2.01	$3.08	$2.60	$3.78	$3.90	$2.13	$12.61	$13.10	$11.96	$11.62	$11.62

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	2.992
Altman Z-Prime	snapshot only																				2.798
Piotroski F-Score	4	3	4	4	4	5	4	7	5	5	6	4	5	4	6	5	4	4	4	5	5
Beneish M-Score	—	—	—	-1.49	-0.65	-2.45	-2.48	-2.68	-2.88	-2.20	-2.32	-1.81	-1.98	-1.28	-1.64	-2.26	-1.38	-1.99	-1.97	-2.10	-2.101
Ohlson O-Score	snapshot only																				-6.042
Net-Net WC	snapshot only																				$-15.35
EVA	snapshot only																				$-75321766.55

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				BBB-
Credit Score	89.23	88.69	88.23	69.22	79.42	87.30	85.22	86.64	86.84	80.38	72.55	68.23	71.67	64.25	68.24	62.34	39.16	41.09	42.13	53.22	53.216
Credit Grade	snapshot only																				10
Credit Trend	snapshot only																				-9.124
Implied Spread (bps)	snapshot only																				350.000
Industry Credit Rank	snapshot only																				48
Sector Credit Rank	snapshot only																				47

ASTH NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet